Skip to main content

Advertisement

Table 1 Correlations between PXN expression and clinicopathological characteristics in gastric cancer patients

From: Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer

   PXN expression  
Characteristics Total No. Low No. cases (%) High No. cases (%) P value
Age     0.742
 < 60 116 75(49.3) 41(47.1)  
 ≥ 60 123 77(50.7) 46(52.9)  
Gender     0.096
 Male 177 118(77.6) 59(67.8)  
 Female 62 34(22.4) 28(32.2)  
Tumor depth     0.527
 T1 11 9(5.9) 2(2.3)  
 T2 29 20(13.2) 9(10.3)  
 T3 176 109(71.7) 67(77.0)  
 T4 23 14(9.2) 9(10.4)  
Lymph node invasion     0.656
 N0 55 35(23.0) 20(22.9)  
 N1 85 58(38.2) 27(31.0)  
 N2 64 39(25.6) 25(28.7)  
 N3 35 20(13.2) 15(17.4)  
Distant metastasis     0.001a
 M0 173 121(79.6) 52(59.7)  
 M1 66 31(20.4) 35(40.3)  
Differentiation status     0.388
 Well 99 68(44.7) 31(35.6)  
 Moderate 92 55(36.1) 37(42.5)  
 Poor and others 48 29(19.2) 19(21.9)  
TNMb stage     0.021a
 I 28 20(13.1) 8(9.1)  
 II 37 23(15.1) 14(16.1)  
 III 100 72(47.3) 28(32.2)  
 IV 74 37(24.5) 37(42.6)  
Treatment     0.386
 Surgery only 116 77(50.7) 39(44.8)  
 Surgery + chemotherapy 123 75(49.3) 48(55.2)  
Survival status     0.004a
 Alive 98 73(48.0) 25(28.7)  
 Dead 141 79(52.0) 62(71.3)  
  1. aP< 0.05, Chi-square test; bTNM: T, tumor; N, lymph node; M, distant metastasis.